These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37855038)

  • 1. Podocyte injury at young age causes premature senescence and worsens glomerular aging.
    Veloso Pereira BM; Zeng Y; Maggiore JC; Schweickart RA; Eng DG; Kaverina N; McKinzie SR; Chang A; Loretz CJ; Thieme K; Hukriede NA; Pippin JW; Wessely O; Shankland SJ
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F120-F134. PubMed ID: 37855038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
    Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
    Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with a
    Cunanan J; Rajyam SS; Sharif B; Udwan K; Rana A; De Gregorio V; Ricardo S; Elia A; Brooks B; Weins A; Pollak M; John R; Barua M
    Am J Physiol Renal Physiol; 2024 May; 326(5):F704-F726. PubMed ID: 38482556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte Senescence and Aging.
    Shankland SJ; Rule AD; Kutz JN; Pippin JW; Wessely O
    Kidney360; 2023 Dec; 4(12):1784-1793. PubMed ID: 37950369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound effects of aging and experimental FSGS on glomerular epithelial cells.
    Schneider RR; Eng DG; Kutz JN; Sweetwyne MT; Pippin JW; Shankland SJ
    Aging (Albany NY); 2017 Feb; 9(2):524-546. PubMed ID: 28222042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
    Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
    Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
    Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
    J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease.
    Pippin JW; Kaverina N; Wang Y; Eng DG; Zeng Y; Tran U; Loretz CJ; Chang A; Akilesh S; Poudel C; Perry HS; O'Connor C; Vaughan JC; Bitzer M; Wessely O; Shankland SJ
    J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35968783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocytes from hypertensive and obese mice acquire an inflammatory, senescent, and aged phenotype.
    McKinzie SR; Kaverina N; Schweickart RA; Chaney CP; Eng DG; Pereira BMV; Kestenbaum B; Pippin JW; Wessely O; Shankland SJ
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F644-F660. PubMed ID: 38420674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
    Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
    Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting glomerulus: role of angiotensin-II type 2 receptor.
    Patel S; Kulkarni K; Hussain T
    Clin Sci (Lond); 2022 Oct; 136(20):1467-1470. PubMed ID: 36287192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK mediates regulation of glomerular volume and podocyte survival.
    Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.